Title: Reimar Schlingensiepen: Innovator in Bioconjugate Chemistry
Introduction
Reimar Schlingensiepen is an inventor based in Wuppertal, Germany. He has made significant contributions to the field of bioconjugate chemistry, particularly in the development of oligonucleotide and protein conjugates. Although he currently holds no granted patents, his work has the potential to impact various applications in biotechnology and medicine.
Latest Patent Applications
One of his notable patent applications is titled "Oligonucleotide-, Protein and/or Peptide-Polymer Conjugates." This application describes a conjugate or compound that comprises polyethylene glycol and an oligonucleotide. In this invention, at least one polyethylene glycol is linked to the 5'-end of the oligonucleotide, and at least one polyethylene glycol is linked to the 3'-end. The application specifies that the molecular weight of the polyethylene glycol linked to both ends of the oligonucleotide is identical and is less than 5000 Da, or that the molecular weights are different.
Conclusion
Reimar Schlingensiepen's innovative work in bioconjugate chemistry showcases his potential as an inventor, despite not having any granted patents at this time. His contributions to the field may pave the way for future advancements in biotechnology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.